All News about Neuropace Inc![]() From NeuroPace, Inc.
Via GlobeNewswire
![]()
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
November 30, 2022
From NeuroPace, Inc.
Via Business Wire
![]() Via Benzinga
![]() ![]() ![]() ![]()
12 Health Care Stocks Moving In Thursday's After-Market Session
November 24, 2022
Via Benzinga
![]()
Stocks That Hit 52-Week Lows On Monday
November 14, 2022
Via Benzinga
![]()
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 08, 2022
From NeuroPace, Inc.
Via GlobeNewswire
![]() From NeuroPace, Inc.
Via GlobeNewswire
![]() ![]() ![]() From NeuroPace, Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript
November 11, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|